Central African Republic

Malaria prevalence, cases, map, treatment, risk and deaths in Central African Republic

Malaria remains the top reason for medical consultations among the general population (42.3 %) and among internally displaced people it accounts for 47.1 % of consultations.  Between 2015 and 2018, case numbers fell by 9% from 380 to 347 per 1000 of the population at risk while deaths fell by 25% from 0.68 to 0.52 per 1000 of the population at risk.3 The country’s complex military and political crisis however leaves it exposed to epidemics.1, 2

Malaria in young children

Malaria prevalence among children aged six to 59 months, (using RDT testing rate as a proxy) was 73% in 2017. This rate varies, however, by region (ranging from 90% in the north and eastern regions, 70% in the western regions and 20% in the southern regions).1

Malaria case management and control

Artemether-lumefantrine is used for the treatment of uncomplicated malaria while injectable artesunate and injectable artemether as well as injectable quinine are used for severe malaria.1 For patients with signs of severe malaria, community health workers administered artesunate rectal capsules (ARC) before referring them to the nearest health facility. 

About 60% of those at risk were protected by either indoor residual spraying (IRS) or insecticide treated nets (ITN).1

Health facilities

According to reports from malaria focal points, there were approximately 989 health care facilities in the
Central African Republic in 2015, of which 835 were operational while 154 of these are non-operational.1

The country drew up a national malaria control policy in 2016, in line with the Global Technical Strategy for Malaria 2016-2030. The plan included adopting the World Health Organization’s recommendation on Intermittent preventative treatment of malaria in pregnancy (IPTp).1

In-patient malaria cases and deaths

Photo: World Malaria Report 2018

Malaria distribution

Photo: World Malaria Report CAR country profile 2018

Severe malaria policy and practice

National Treatment Guidelines
Recommendation Treatment
Strong Injectable artesunate (IV)
Alternative Injectable artemether
Alternative Injectable quinine
Recommendation Pre-Referral
Alternative Intramuscular artesunate
Alternative Intramuscular quinine
Alternative Rectal artesunate
Alternative Rectal quinine